
医学资讯HFpEF克隆性造血
借助克隆性造血蛋白组学特征预测HFpEF预后
By MedXY|2026年9月24日
本研究识别出与克隆性造血驱动突变相关的血浆蛋白组学特征,并构建了一项蛋白组学风险评分,可独立预测射血分数保留性心力衰竭(HFpEF)的不良临床结局。
Our website uses essential cookies and, with your consent, additional cookies to measure performance and improve our services. Cookie Policy.
You can change your choice at any time.